Transcriptomics

Dataset Information

0

P53 Represses the Mevalonate Pathway to Mediate Tumor Suppression


ABSTRACT: We have discovered that loss of wild-type p53 correlates with elevated expression of mevalonate pathway genes in murine liver cancer and in human tumors. Mechanistically p53 blocks activation of SREBP-2, the master transcriptional regulator of this pathway, by transcriptionally inducing the ABCA1 cholesterol transporter gene, which inhibits SREBP-2 maturation. In mice the increase in mevalonate gene expression occurs in premalignant p53-null hepatocytes at a stage when p53 is needed to actively suppress tumorigenesis. Either RNAi mediated suppression of key genes in the mevalonate pathway or pharmacological inhibition of its rate-limiting enzyme restricts the development of mouse hepatocellular carcinomas driven by p53 loss. Conversely, like p53 loss, ablation of ABCA1 promotes tumorigenesis in a murine model and is associated with increased SREBP-2 maturation. Our findings thereby demonstrate that repression of the mevalonate pathway is a crucial component of p53-mediated tumor suppression and outline the mechanism by which this occurs.

ORGANISM(S): Mus musculus

PROVIDER: GSE121558 | GEO | 2018/10/23

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2012-02-13 | E-GEOD-31812 | biostudies-arrayexpress
2012-02-13 | GSE31812 | GEO
| PRJNA497787 | ENA
2022-10-03 | GSE214508 | GEO
2022-10-03 | GSE214507 | GEO
2019-11-15 | GSE124189 | GEO
2018-04-25 | GSE104729 | GEO
| PRJNA145251 | ENA
2015-08-17 | E-GEOD-31812 | ExpressionAtlas
2022-04-05 | GSE174173 | GEO